Sigurbergur Karason

Prof. Dr. Sigurbergur Karason


Research Focus & Metrics

Academic Career Length

26Years (2001-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 January 2011 in Trials
Verified
Journal Article
Open access
PDF file
TGthe Scandinavian Critical Care Trials Group
the Scandinavian Critical Care Trials Group
APAnders Perner
Anders Perner
NHNicolai Haase
Nicolai Haase
JWJørn Wetterslev
Jørn Wetterslev
AAAnders Aneman
Anders Aneman
JWJan Wernerman
Jan Wernerman
By tradition colloid solutions have been used to obtain fast circulatory stabilisation in shock, but high molecular weight hydroxyethyl starch (HES) may cause acute kidney failure in patients with severe sepsis. Now lower molecular weight HES 130/0.4 is the preferred colloid in Scandinavian intensive care units (ICUs) and 1st choice fluid for patients with severe sepsis. However, HES 130/0.4 is largely unstudied in patients with severe sepsis. The 6S trial will randomise 800 patients with severe sepsis in 30 Scandinavian ICUs to masked fluid resuscitation using either 6% HES 130/0.4 in Ringer's acetate or Ringer's acetate alone. The composite endpoint of 90-day mortality or end-stage kidney failure is the primary outcome measure. The secondary outcome measures are severe bleeding or allergic reactions, organ failure, acute kidney failure, days alive without renal replacement therapy or ventilator support and 28-day and 1/2- and one-year mortality. The sample size will allow the detection of a 10% absolute difference between the two groups in the composite endpoint with a power of 80%. The 6S trial will provide important safety and efficacy data on the use of HES 130/0.4 in patients with severe sepsis. The effects on mortality, dialysis-dependency, time on ventilator, bleeding and markers of resuscitation, metabolism, kidney failure, and coagulation will be assessed. ClinicalTrials.gov: NCT00962156

6 June 2014 in Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine
Verified
Journal Article
Open access
PDF file
SKSigurbergur Karason
Sigurbergur Karason
KRKristbjorn Reynisson
Kristbjorn Reynisson
KSKristinn Sigvaldason
Kristinn Sigvaldason
GSGisli H Sigurdsson
Gisli H Sigurdsson
Concern has been raised that cervical collars may increase intracranial pressure in traumatic brain injury. The purpose of this study was to compare four types of cervical collars regarding efficacy of immobilizing the neck, effect on jugular venous pressure (JVP), as a surrogate for possible effect on intracranial pressure, and patient comfort in healthy volunteers.

25 February 2013 in Acta Anaesthesiologica Scandinavica
Verified
Journal Article
Closed access
PDF file
SKSigurbergur Karason
Sigurbergur Karason
TOT. A. Olafsson
T. A. Olafsson

4 May 2021 in Acta Anaesthesiologica Scandinavica
Verified
Journal Article
Closed access
PDF file
GGGudrun M. Gunnarsdottir
Gudrun M. Gunnarsdottir
SHSolveig Helgadottir
Solveig Helgadottir
SESveinn G. Einarsson
Sveinn G. Einarsson
KHKari Hreinsson
Kari Hreinsson
JWJohn Whittle
John Whittle
MSMartin I. Sigurdsson
Martin I. Sigurdsson

3 October 2002 in Acta Anaesthesiologica Scandinavica
Verified
Journal Article
Closed access
PDF file
SKSigurbergur Karason
Sigurbergur Karason
KAK. Antonsen
K. Antonsen
AAAnders Aneman
Anders Aneman
TGThe SSAI ICU‐II GROUP
The SSAI ICU‐II GROUP

19 March 2019 in Acta Anaesthesiologica Scandinavica
Verified
Journal Article
Open access
PDF file
EVEdda Vesteinsdottir
Edda Vesteinsdottir
KHKristjan Orri Helgason
Kristjan Orri Helgason
KSKristinn Orn Sverrisson
Kristinn Orn Sverrisson
OGOlafur Gudlaugsson
Olafur Gudlaugsson
SKSigurbergur Karason
Sigurbergur Karason
Background: Infections are a frequent complication of cardiac surgery. The intraoperative use of transesophageal echocardiography (TEE) may be an underrecognized risk factor for post‐operative infections. The aim of this study was to investigate infection rates and outcomes after cardiac surgery in a nationwide cohort, especially in relation to periods where surface damaged TEE probes were used.Methods: This was a retrospective, observational study at Landspitali University Hospital. All consecutive cardiac surgery patients from 1 January 2013 to 31 December 2017 were included. Patients’ charts were reviewed for evidence of infection, post‐operative complications or death.Results: During the study period, 973 patients underwent cardiac surgery at Landspitali and 198 (20.3%) developed a post‐operative infection. The most common infections were: Pneumonia (9.1%), superficial surgical site (5.7%), bloodstream (2.8%) and deep sternal wound (1.7%). Risk factors for developing an infection included: The duration of procedure, age, insulin‐dependent diabetes, EuroScore II, reoperation for bleeding and an operation in a period with a surface damaged TEE probe in use. Twenty‐two patients were infected with a multidrug resistant strain of Klebsiella oxytoca, 10 patients with Pseudomonas aeruginosa and two patients developed endocarditis with Enterococcus faecalis. All three pathogens were cultured from the TEE probe in use at respective time, after decontamination. The 30‐day mortality rate in the patient cohort was 3.2%.Conclusions: The intraoperative use of surface damaged TEE probes caused two serious infection outbreaks in patients after cardiac surgery. TEE probes need careful visual inspection during decontamination and probe sheaths are recommended.